KS

Kumud Singh

Active Director Director DIN 08157324
DIN 08157324 First appointment Jun 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2018
Shareholding value •••• Premium profile

About Kumud Singh

Data last updated:

Kumud Singh is a Director at Shytavia Pharma Private Limited (since 2018). The company operates in Trading. Shytavia Pharma Private Limited reported revenue of ₹14.2 Lakh (FY 2025).

DIN 08157324
Primary Designation Director
Industry Trading
First Appointment 14 Jun 2018
Oldest Company Age 8 yrs
Largest company Shytavia Pharma Private Limited · ₹14.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shytavia Pharma Private Limited U51909UP2018PTC105289
Director14 Jun 20182018₹14.2 Lakh (FY 2025)Active

Board colleagues of Kumud Singh

NameDINCompanyDesignation
Ramakant Singh08157323Shytavia Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Shytavia Pharma Private Limited
Premium access

Shareholding and investment profile for Kumud Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumud Singh

Kumud Singh currently holds 1 directorship: Shytavia Pharma Private Limited (Director, since 14 Jun 2018, revenue ₹14.2 Lakh (FY 2025)).

Kumud Singh was first appointed on 14 Jun 2018 as Director at Shytavia Pharma Private Limited.

The current boards of Kumud Singh's companies include Ramakant Singh (Shytavia Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available